Buy 100 Share at $ 263 and sell covered Call for $ 255 for 18 Aug and collect Premium $ 8.05
Devidend Ex date 17 Aug means stock must be purchased before 16 Aug and record date 18 Aug Devidend pay out Date: 8 th Sep
Outcome: We buy Share and get it assigned to Call buyer and we colelct devidend for Free
Q 2 Devidend is $ 2 .13 Per share
Every 100 Share you...
Have a board meeting with the governor or something. Health care policy, life insurances, Even ambulences.... Thats a big deal. So go fulll oligarchy, aristrocrat!
Introduction:
I'm excited to share my trading journey on TradingView, where I'll be posting a carefully curated list of 10 stocks every trading day, and sometimes even multiple times a day. Through this endeavor, I aim to foster a dynamic environment where market enthusiasts can stay informed and engaged with real-time insights.
Why 10 Stocks?
The selection...
Amgen Inc. (AMGN) approaching significant resistance, able to absorb weekly buying pressures. From here (AMGN) can fall back to channel support, eliciting losses of 20% over the following 3-5 months. Inversely, if a settlement above this resistance level occurs, (AMGN) would be placed into a buy signal where gains of 20% would be expected over the following 5-6 months.
The PEAD projected a bullish outlook for NASDAQ:AMGN after a negative over reaction following its earnings release placing the stock in drift C with an expected accuracy of 75%.
Possible swing trade: This is setting up for a 2:1 r/r if you use the newer support line as a stop and the area of resistance as a profit taking point. Depending on your appetite for risk, it would also be an option to use the stronger support line as your hard stop. Recent news about Prolia reducing fracture risk compared to a competitor is positive. DYOR...
Keep Amgen on your radar. It has formed a rather large cup and I've measured the conservative parameters for the cup height.
Conservative price target: FWB:280
No position yet but I'll be watching the daily candles and volume to snipe the entry when it reverses.
Stay tuned!
Summary
Amgen has realized positive revenue growth, despite today's challenging operating environment.
The company has positive catalysts, such as acquisitions, and a positive product pipeline, which support the acceleration of revenue growth and position it well for long-term success.
Additionally, AMGN is expanding its biomanufacturing capacity to cater to...
Amgen is out of the accumulation phase and looking good for a short-term buy. This is a technical analysis, do your fundamental analysis. If the price sustains above the blue box, hold it for the mid-term and keep SL tight as there is no need to book loss here. use the above resistance bands to trail SL till the top... if the price rejects at certain levels, these...
On this chart the price is in a clear rising channel: lower band is acting as support and upper band is acting as resistance. At this time the price is going down, but it's still in the mid of the range. So the best thing to do is to wait for the price to hit the support in order to enter a long position.
Target/take profit is displayed on the chart (295,87)
AMGN Day Setup for Long Call:
1- Current trend is bullish
2- Trend line is respected many times
3- currently the price has touched the trendline to make its HL and moving up to make HH
4- next support is at 229
5- next resistance is at 256
6- RSI is oversold at 1D view
Entry: 245
SL: 228
TP: 285
RRR: 1:2.5
Price has broken the bottom line.
No recommendation.
Short is less than 2%.
EPS (FWD)
17.67
PE (FWD)
14.52
Div Rate (FWD)
$8.52
Yield (FWD)
3.32%
Short Interest
1.68%
Market Cap
$136.88B
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease,...
